Andreas Habertheuer, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lung Transplantation | 7 | 2022 | 1310 | 1.550 |
Why?
|
Heart Neoplasms | 5 | 2020 | 374 | 1.350 |
Why?
|
Aortic Valve Stenosis | 7 | 2022 | 2023 | 1.350 |
Why?
|
Heart Valve Prosthesis | 5 | 2021 | 1464 | 1.300 |
Why?
|
Exosomes | 7 | 2022 | 417 | 1.290 |
Why?
|
Aortic Valve | 14 | 2022 | 1966 | 1.210 |
Why?
|
Aortic Valve Insufficiency | 9 | 2022 | 575 | 1.160 |
Why?
|
Aortic Aneurysm, Thoracic | 5 | 2021 | 708 | 0.880 |
Why?
|
Embolic Protection Devices | 1 | 2022 | 43 | 0.770 |
Why?
|
Cardiac Valve Annuloplasty | 2 | 2018 | 51 | 0.740 |
Why?
|
Heart Valve Diseases | 6 | 2022 | 1029 | 0.720 |
Why?
|
Spinal Cord Ischemia | 1 | 2021 | 94 | 0.700 |
Why?
|
Intracranial Embolism | 1 | 2022 | 188 | 0.690 |
Why?
|
Sinus of Valsalva | 4 | 2020 | 60 | 0.620 |
Why?
|
Extracorporeal Membrane Oxygenation | 5 | 2021 | 1481 | 0.610 |
Why?
|
Aneurysm | 1 | 2021 | 343 | 0.600 |
Why?
|
Aortic Aneurysm | 6 | 2022 | 649 | 0.580 |
Why?
|
Graft Rejection | 6 | 2022 | 4504 | 0.570 |
Why?
|
Postoperative Complications | 11 | 2022 | 15831 | 0.550 |
Why?
|
Endocarditis, Bacterial | 1 | 2021 | 436 | 0.550 |
Why?
|
Endocarditis | 1 | 2021 | 352 | 0.540 |
Why?
|
Heart Valve Prosthesis Implantation | 8 | 2022 | 1564 | 0.540 |
Why?
|
Histocompatibility Testing | 1 | 2018 | 726 | 0.520 |
Why?
|
Myxoma | 1 | 2015 | 114 | 0.460 |
Why?
|
Cardiac Surgical Procedures | 11 | 2021 | 3683 | 0.450 |
Why?
|
Spinal Cord Injuries | 1 | 2021 | 927 | 0.440 |
Why?
|
Superior Vena Cava Syndrome | 1 | 2014 | 55 | 0.430 |
Why?
|
Heart Aneurysm | 1 | 2013 | 114 | 0.430 |
Why?
|
Aorta | 7 | 2022 | 2043 | 0.420 |
Why?
|
Pharmaceutical Preparations | 1 | 2021 | 1086 | 0.410 |
Why?
|
Lipoma | 1 | 2014 | 294 | 0.400 |
Why?
|
Reoperation | 8 | 2020 | 4325 | 0.400 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2021 | 1250 | 0.380 |
Why?
|
Heart Atria | 2 | 2014 | 1362 | 0.380 |
Why?
|
Cardiotonic Agents | 1 | 2014 | 541 | 0.370 |
Why?
|
Thoracotomy | 1 | 2013 | 374 | 0.370 |
Why?
|
Treatment Outcome | 30 | 2023 | 65286 | 0.350 |
Why?
|
Heart Transplantation | 3 | 2019 | 3306 | 0.340 |
Why?
|
Endovascular Procedures | 2 | 2021 | 2215 | 0.340 |
Why?
|
Blood Vessel Prosthesis Implantation | 6 | 2022 | 1456 | 0.340 |
Why?
|
Aorta, Thoracic | 5 | 2020 | 1110 | 0.340 |
Why?
|
Stroke | 3 | 2022 | 9744 | 0.330 |
Why?
|
Transplantation, Homologous | 1 | 2018 | 4860 | 0.320 |
Why?
|
Coronary Artery Bypass | 5 | 2023 | 2189 | 0.300 |
Why?
|
Myocardial Ischemia | 2 | 2019 | 2131 | 0.300 |
Why?
|
Microsurgery | 1 | 2013 | 798 | 0.290 |
Why?
|
Prosthesis Design | 4 | 2022 | 2120 | 0.270 |
Why?
|
Risk Assessment | 7 | 2021 | 24299 | 0.260 |
Why?
|
Emergency Treatment | 2 | 2020 | 495 | 0.260 |
Why?
|
Shock, Cardiogenic | 3 | 2021 | 709 | 0.260 |
Why?
|
Islets of Langerhans Transplantation | 3 | 2019 | 747 | 0.240 |
Why?
|
Databases, Factual | 8 | 2020 | 8065 | 0.230 |
Why?
|
Pacemaker, Artificial | 3 | 2015 | 828 | 0.230 |
Why?
|
Sarcoma | 1 | 2015 | 1802 | 0.220 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2014 | 1433 | 0.220 |
Why?
|
Carotid Artery Diseases | 2 | 2020 | 872 | 0.210 |
Why?
|
Survival Rate | 8 | 2020 | 12826 | 0.210 |
Why?
|
Aged | 32 | 2022 | 171344 | 0.200 |
Why?
|
Rats, Wistar | 3 | 2022 | 1887 | 0.200 |
Why?
|
Retrospective Studies | 25 | 2022 | 81657 | 0.200 |
Why?
|
Replantation | 2 | 2022 | 145 | 0.200 |
Why?
|
Humans | 62 | 2023 | 766812 | 0.190 |
Why?
|
Hospital Mortality | 6 | 2021 | 5344 | 0.190 |
Why?
|
Coronary Artery Disease | 4 | 2023 | 6575 | 0.190 |
Why?
|
Echocardiography, Transesophageal | 3 | 2018 | 1093 | 0.190 |
Why?
|
Male | 43 | 2022 | 364154 | 0.180 |
Why?
|
Tricuspid Valve Insufficiency | 2 | 2015 | 361 | 0.180 |
Why?
|
Myocardium | 1 | 2013 | 4765 | 0.180 |
Why?
|
Female | 41 | 2022 | 396532 | 0.180 |
Why?
|
Rodentia | 1 | 2022 | 262 | 0.180 |
Why?
|
Microfilament Proteins | 2 | 2016 | 1130 | 0.180 |
Why?
|
Time Factors | 16 | 2022 | 40149 | 0.170 |
Why?
|
Tissue Donors | 2 | 2022 | 2392 | 0.170 |
Why?
|
Rats, Inbred Lew | 1 | 2022 | 1168 | 0.170 |
Why?
|
Blood Circulation | 1 | 2020 | 248 | 0.160 |
Why?
|
Carotid Arteries | 2 | 2020 | 932 | 0.160 |
Why?
|
Vascular Surgical Procedures | 4 | 2020 | 1506 | 0.160 |
Why?
|
Angiogenic Proteins | 1 | 2019 | 101 | 0.150 |
Why?
|
Antigen-Presenting Cells | 1 | 2022 | 960 | 0.150 |
Why?
|
Cell-Derived Microparticles | 1 | 2020 | 159 | 0.150 |
Why?
|
Trophoblasts | 1 | 2020 | 223 | 0.150 |
Why?
|
Carbon Isotopes | 1 | 2019 | 453 | 0.150 |
Why?
|
Shock, Surgical | 1 | 2017 | 10 | 0.150 |
Why?
|
Pyruvic Acid | 1 | 2019 | 205 | 0.150 |
Why?
|
Autocrine Communication | 1 | 2019 | 168 | 0.150 |
Why?
|
Sternum | 1 | 2019 | 177 | 0.150 |
Why?
|
Sternotomy | 2 | 2019 | 134 | 0.140 |
Why?
|
Follow-Up Studies | 8 | 2020 | 39312 | 0.140 |
Why?
|
Paracrine Communication | 1 | 2019 | 277 | 0.140 |
Why?
|
Corneal Neovascularization | 1 | 2019 | 184 | 0.140 |
Why?
|
Middle Aged | 28 | 2022 | 223267 | 0.140 |
Why?
|
Stents | 2 | 2020 | 3193 | 0.140 |
Why?
|
Rats | 3 | 2022 | 23717 | 0.140 |
Why?
|
Bioprosthesis | 1 | 2020 | 593 | 0.130 |
Why?
|
Risk Factors | 13 | 2022 | 74889 | 0.130 |
Why?
|
Erythrocyte Transfusion | 1 | 2020 | 574 | 0.120 |
Why?
|
Animals | 15 | 2022 | 168939 | 0.120 |
Why?
|
Catheterization, Central Venous | 1 | 2020 | 538 | 0.120 |
Why?
|
Aged, 80 and over | 7 | 2020 | 59548 | 0.120 |
Why?
|
Pneumonia, Mycoplasma | 1 | 2015 | 50 | 0.120 |
Why?
|
Kidney Transplantation | 3 | 2019 | 4278 | 0.120 |
Why?
|
Heart Diseases | 2 | 2020 | 2817 | 0.120 |
Why?
|
Primary Graft Dysfunction | 1 | 2015 | 112 | 0.120 |
Why?
|
Papillary Muscles | 1 | 2015 | 192 | 0.120 |
Why?
|
Recovery of Function | 3 | 2019 | 2978 | 0.120 |
Why?
|
Pulmonary Valve Stenosis | 1 | 2015 | 164 | 0.110 |
Why?
|
Preoperative Care | 2 | 2020 | 2253 | 0.110 |
Why?
|
Tricuspid Valve | 1 | 2017 | 419 | 0.110 |
Why?
|
Recurrence | 4 | 2020 | 8507 | 0.110 |
Why?
|
Cardiopulmonary Bypass | 2 | 2020 | 1097 | 0.110 |
Why?
|
Blood Vessel Prosthesis | 1 | 2018 | 956 | 0.110 |
Why?
|
Blood Proteins | 1 | 2019 | 1194 | 0.110 |
Why?
|
Spinal Cord | 1 | 2021 | 1811 | 0.110 |
Why?
|
Rats, Inbred WKY | 1 | 2013 | 150 | 0.110 |
Why?
|
Adult | 17 | 2022 | 223305 | 0.100 |
Why?
|
Cohort Studies | 7 | 2020 | 41706 | 0.100 |
Why?
|
Mitral Valve Stenosis | 1 | 2015 | 342 | 0.100 |
Why?
|
Pulmonary Edema | 1 | 2015 | 409 | 0.100 |
Why?
|
Ischemia | 1 | 2021 | 1905 | 0.100 |
Why?
|
Cardiac Tamponade | 1 | 2014 | 175 | 0.100 |
Why?
|
Lung | 3 | 2022 | 10068 | 0.100 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 1 | 2015 | 210 | 0.100 |
Why?
|
Electrophysiological Phenomena | 1 | 2014 | 309 | 0.100 |
Why?
|
Vascular Resistance | 1 | 2015 | 939 | 0.100 |
Why?
|
Patient Readmission | 3 | 2021 | 3283 | 0.100 |
Why?
|
Capillary Permeability | 1 | 2016 | 772 | 0.100 |
Why?
|
Molecular Imaging | 1 | 2019 | 822 | 0.100 |
Why?
|
ROC Curve | 1 | 2020 | 3621 | 0.100 |
Why?
|
Rats, Inbred F344 | 1 | 2013 | 820 | 0.100 |
Why?
|
Perfusion | 1 | 2017 | 1409 | 0.100 |
Why?
|
Reperfusion Injury | 1 | 2018 | 1043 | 0.100 |
Why?
|
Neovascularization, Physiologic | 1 | 2019 | 1368 | 0.090 |
Why?
|
Heart Ventricles | 2 | 2014 | 3831 | 0.090 |
Why?
|
Renal Dialysis | 1 | 2021 | 1790 | 0.090 |
Why?
|
Dissection | 1 | 2013 | 298 | 0.090 |
Why?
|
Lymphoma | 1 | 2020 | 1899 | 0.090 |
Why?
|
Pericardium | 1 | 2016 | 681 | 0.090 |
Why?
|
Models, Animal | 2 | 2019 | 2121 | 0.090 |
Why?
|
Postoperative Care | 1 | 2017 | 1480 | 0.090 |
Why?
|
Islets of Langerhans | 1 | 2017 | 1350 | 0.090 |
Why?
|
Stem Cell Transplantation | 1 | 2019 | 1600 | 0.090 |
Why?
|
Lymph Nodes | 1 | 2022 | 3468 | 0.090 |
Why?
|
Pre-Eclampsia | 1 | 2020 | 1256 | 0.090 |
Why?
|
Surgical Wound Infection | 1 | 2019 | 1547 | 0.080 |
Why?
|
Biopsy, Needle | 1 | 2014 | 1615 | 0.080 |
Why?
|
Mice, Inbred C57BL | 5 | 2019 | 22351 | 0.080 |
Why?
|
Age Factors | 3 | 2020 | 18397 | 0.080 |
Why?
|
Blood-Brain Barrier | 1 | 2016 | 1028 | 0.080 |
Why?
|
Rare Diseases | 1 | 2014 | 630 | 0.080 |
Why?
|
Mice, Inbred BALB C | 1 | 2018 | 6225 | 0.080 |
Why?
|
Hyperglycemia | 1 | 2017 | 1389 | 0.080 |
Why?
|
Membrane Proteins | 2 | 2016 | 7869 | 0.080 |
Why?
|
Mitral Valve | 1 | 2017 | 1473 | 0.080 |
Why?
|
Inflammation | 2 | 2018 | 10863 | 0.080 |
Why?
|
T-Lymphocytes | 2 | 2023 | 10263 | 0.080 |
Why?
|
Pulmonary Embolism | 1 | 2021 | 2596 | 0.070 |
Why?
|
Academic Medical Centers | 1 | 2018 | 2783 | 0.070 |
Why?
|
Ventricular Function, Left | 1 | 2020 | 3934 | 0.070 |
Why?
|
Critical Illness | 1 | 2020 | 2750 | 0.070 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2019 | 3446 | 0.070 |
Why?
|
Logistic Models | 2 | 2019 | 13276 | 0.070 |
Why?
|
Liver Transplantation | 1 | 2019 | 2416 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 2 | 2017 | 6514 | 0.070 |
Why?
|
Dyspnea | 1 | 2014 | 1352 | 0.070 |
Why?
|
Stem Cells | 1 | 2019 | 3536 | 0.070 |
Why?
|
Adipose Tissue | 1 | 2018 | 3317 | 0.060 |
Why?
|
Prospective Studies | 2 | 2020 | 54872 | 0.060 |
Why?
|
Brain Ischemia | 1 | 2018 | 3001 | 0.060 |
Why?
|
Heart Arrest | 1 | 2014 | 1516 | 0.060 |
Why?
|
Acute Disease | 3 | 2020 | 7240 | 0.060 |
Why?
|
Longitudinal Studies | 1 | 2020 | 14762 | 0.060 |
Why?
|
Organ Specificity | 2 | 2020 | 1968 | 0.060 |
Why?
|
Cytokines | 1 | 2019 | 7438 | 0.050 |
Why?
|
Macrophages | 1 | 2018 | 5784 | 0.050 |
Why?
|
Disease Models, Animal | 3 | 2019 | 18329 | 0.050 |
Why?
|
Immunotherapy | 1 | 2019 | 4747 | 0.050 |
Why?
|
Peptide Fragments | 1 | 2015 | 5143 | 0.050 |
Why?
|
Endothelial Cells | 1 | 2016 | 3582 | 0.050 |
Why?
|
Atherosclerosis | 1 | 2018 | 3421 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3110 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3232 | 0.050 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2014 | 2763 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 5888 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2018 | 15425 | 0.050 |
Why?
|
United States | 5 | 2020 | 72945 | 0.050 |
Why?
|
RNA, Messenger | 3 | 2023 | 12795 | 0.050 |
Why?
|
Thrombosis | 1 | 2015 | 2953 | 0.050 |
Why?
|
Immunohistochemistry | 1 | 2014 | 11062 | 0.050 |
Why?
|
Mice | 3 | 2018 | 81898 | 0.040 |
Why?
|
Hospitalization | 1 | 2020 | 10816 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2019 | 20146 | 0.040 |
Why?
|
Rats, Nude | 1 | 2019 | 105 | 0.040 |
Why?
|
Gene Products, env | 1 | 2020 | 250 | 0.040 |
Why?
|
Pennsylvania | 1 | 2020 | 615 | 0.040 |
Why?
|
Pregnancy Proteins | 1 | 2020 | 222 | 0.040 |
Why?
|
Swine | 2 | 2020 | 5985 | 0.040 |
Why?
|
Secretory Pathway | 1 | 2019 | 53 | 0.040 |
Why?
|
Quality of Life | 1 | 2020 | 13476 | 0.040 |
Why?
|
Prognosis | 2 | 2019 | 29959 | 0.040 |
Why?
|
Anticoagulants | 1 | 2014 | 4854 | 0.040 |
Why?
|
Bicuspid | 1 | 2018 | 69 | 0.040 |
Why?
|
Glutamate Decarboxylase | 1 | 2019 | 239 | 0.040 |
Why?
|
Radiography, Thoracic | 2 | 2014 | 1320 | 0.040 |
Why?
|
Gram-Negative Bacteria | 1 | 2019 | 276 | 0.030 |
Why?
|
Spheroids, Cellular | 1 | 2019 | 328 | 0.030 |
Why?
|
Survival Analysis | 2 | 2020 | 10101 | 0.030 |
Why?
|
Glucagon | 1 | 2019 | 534 | 0.030 |
Why?
|
Cell Hypoxia | 1 | 2019 | 661 | 0.030 |
Why?
|
Area Postrema | 1 | 2016 | 6 | 0.030 |
Why?
|
Major Histocompatibility Complex | 1 | 2019 | 880 | 0.030 |
Why?
|
Debridement | 1 | 2019 | 494 | 0.030 |
Why?
|
Thoracic Surgical Procedures | 1 | 2020 | 348 | 0.030 |
Why?
|
Peroxidase | 1 | 2019 | 610 | 0.030 |
Why?
|
Glycosylation | 1 | 2019 | 1099 | 0.030 |
Why?
|
Austria | 1 | 2016 | 206 | 0.030 |
Why?
|
Safety | 1 | 2020 | 1157 | 0.030 |
Why?
|
Systems Biology | 1 | 2019 | 481 | 0.030 |
Why?
|
Swine, Miniature | 1 | 2017 | 972 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 2 | 2019 | 20710 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2015 | 5860 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2019 | 723 | 0.030 |
Why?
|
North America | 1 | 2019 | 1287 | 0.030 |
Why?
|
Virulence | 1 | 2019 | 1294 | 0.030 |
Why?
|
Ventilation | 1 | 2015 | 129 | 0.030 |
Why?
|
Emergency Service, Hospital | 1 | 2014 | 7870 | 0.030 |
Why?
|
Glucose Tolerance Test | 1 | 2017 | 1180 | 0.030 |
Why?
|
Coronary Sinus | 1 | 2015 | 85 | 0.030 |
Why?
|
Hypereosinophilic Syndrome | 1 | 2015 | 97 | 0.030 |
Why?
|
Purkinje Cells | 1 | 2016 | 228 | 0.030 |
Why?
|
Waiting Lists | 1 | 2019 | 779 | 0.030 |
Why?
|
Organ Size | 1 | 2019 | 2262 | 0.030 |
Why?
|
Lactic Acid | 1 | 2019 | 1139 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2019 | 1186 | 0.030 |
Why?
|
Blood Glucose | 2 | 2019 | 6422 | 0.030 |
Why?
|
Mice, SCID | 1 | 2019 | 2626 | 0.030 |
Why?
|
Tight Junctions | 1 | 2016 | 324 | 0.030 |
Why?
|
Pancreatectomy | 1 | 2017 | 825 | 0.030 |
Why?
|
Apolipoproteins E | 1 | 2018 | 1459 | 0.030 |
Why?
|
Thoracic Surgery | 1 | 2019 | 727 | 0.030 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2020 | 996 | 0.020 |
Why?
|
MicroRNAs | 2 | 2019 | 3789 | 0.020 |
Why?
|
Propensity Score | 1 | 2020 | 1972 | 0.020 |
Why?
|
Organ Preservation | 1 | 2015 | 400 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2018 | 1791 | 0.020 |
Why?
|
Foramen Ovale, Patent | 1 | 2014 | 210 | 0.020 |
Why?
|
Electric Impedance | 1 | 2016 | 791 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 2 | 2019 | 36570 | 0.020 |
Why?
|
Actins | 1 | 2018 | 2061 | 0.020 |
Why?
|
Placenta | 1 | 2020 | 1726 | 0.020 |
Why?
|
Mice, Nude | 1 | 2017 | 3618 | 0.020 |
Why?
|
Regression Analysis | 1 | 2020 | 6329 | 0.020 |
Why?
|
Myocytes, Cardiac | 1 | 2019 | 1672 | 0.020 |
Why?
|
Surgical Flaps | 1 | 2019 | 1680 | 0.020 |
Why?
|
Device Removal | 1 | 2015 | 643 | 0.020 |
Why?
|
Heart-Assist Devices | 1 | 2020 | 1287 | 0.020 |
Why?
|
Hemodynamics | 1 | 2020 | 4188 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2017 | 2198 | 0.020 |
Why?
|
Phenotype | 2 | 2019 | 16722 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2019 | 4277 | 0.020 |
Why?
|
Cause of Death | 1 | 2020 | 3717 | 0.020 |
Why?
|
Coronary Stenosis | 1 | 2015 | 804 | 0.020 |
Why?
|
Patient Selection | 1 | 2020 | 4252 | 0.020 |
Why?
|
Risk | 1 | 2020 | 9602 | 0.020 |
Why?
|
Transfection | 1 | 2016 | 5755 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2019 | 3511 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2023 | 8045 | 0.020 |
Why?
|
Proteome | 1 | 2017 | 1894 | 0.020 |
Why?
|
Societies, Medical | 1 | 2019 | 3957 | 0.020 |
Why?
|
Stroke Volume | 1 | 2020 | 5618 | 0.020 |
Why?
|
Cell Line | 1 | 2020 | 15564 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10580 | 0.020 |
Why?
|
Nanoparticles | 1 | 2017 | 1966 | 0.020 |
Why?
|
Clinical Competence | 1 | 2020 | 4858 | 0.010 |
Why?
|
Insulin | 1 | 2019 | 6608 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2016 | 8540 | 0.010 |
Why?
|
Signal Transduction | 2 | 2019 | 23618 | 0.010 |
Why?
|
Young Adult | 2 | 2020 | 59939 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2017 | 12536 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 22248 | 0.010 |
Why?
|
Echocardiography | 1 | 2014 | 5038 | 0.010 |
Why?
|
Genotype | 1 | 2016 | 13036 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2018 | 11924 | 0.010 |
Why?
|
Incidence | 1 | 2019 | 21527 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2016 | 14473 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2019 | 7475 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2016 | 18986 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2016 | 10451 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8734 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 11876 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2015 | 12985 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2019 | 11514 | 0.010 |
Why?
|
Pregnancy | 1 | 2020 | 30236 | 0.010 |
Why?
|
Obesity | 1 | 2018 | 13090 | 0.010 |
Why?
|
Heart Failure | 1 | 2019 | 11879 | 0.010 |
Why?
|
Adolescent | 1 | 2018 | 88902 | 0.010 |
Why?
|